BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32910350)

  • 1. NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics.
    Wong KS; Mariño-Enriquez A; Hornick JL; Jo VY
    Head Neck Pathol; 2021 Jun; 15(2):425-432. PubMed ID: 32910350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NR4A3 Immunostain Is a Highly Sensitive and Specific Marker for Acinic Cell Carcinoma in Cytologic and Surgical Specimens.
    Viswanathan K; Beg S; He B; Zhang T; Cantley R; Lubin DJ; Shi Q; Maleki Z; Asiry S; Rao R; Katabi N; Nakaguro M; Faquin WC; Sadow PM; Siddiqui MT; Scognamiglio T
    Am J Clin Pathol; 2022 Jan; 157(1):98-108. PubMed ID: 34508546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands.
    Haller F; Skálová A; Ihrler S; Märkl B; Bieg M; Moskalev EA; Erber R; Blank S; Winkelmann C; Hebele S; Baněčková M; Wiemann S; Müller S; Zenk J; Eils R; Iro H; Hartmann A; Agaimy A
    Am J Surg Pathol; 2019 Sep; 43(9):1264-1272. PubMed ID: 31094928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of NR4A3/NOR-1 in acinic cell carcinoma of the salivary gland].
    Cheng K; Wang X; Wei X; Ma J; Xia QY; Shi QL; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1142-1146. PubMed ID: 33152819
    [No Abstract]   [Full Text] [Related]  

  • 5. A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors.
    Klubíčková N; Grossmann P; Šteiner P; Baněčková M; Mosaieby E; Koshyk O; Michal M; Leivo I; Skálová A
    Virchows Arch; 2023 Feb; 482(2):339-345. PubMed ID: 36469101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of NR4A3 on FNA cytology smears and liquid-based preparations of salivary gland.
    Millan N; Tjendra Y; Zuo Y; Jorda M; Garcia-Buitrago M; Velez-Torres JM; Gomez-Fernandez C
    Cancer Cytopathol; 2022 Dec; 130(12):949-954. PubMed ID: 35913415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma.
    Skaugen JM; Seethala RR; Chiosea SI; Landau MS
    Cancer Cytopathol; 2021 Feb; 129(2):104-113. PubMed ID: 32809265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma.
    Zhu L; Sun L; Zhang Y; Liu X; Li X; Zhou Z; Cui Y; Zhou CX; Li TJ
    Am J Surg Pathol; 2024 Jun; 48(6):681-690. PubMed ID: 38682454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOR-1 distinguishes acinic cell carcinoma from its mimics on fine-needle aspiration biopsy specimens.
    Nguyen L; Chopra S; Laskar DB; Rao J; Lieu D; Chung F; Kim ED; de Peralta-Venturina M; Bose S; Balzer B
    Hum Pathol; 2020 Aug; 102():1-6. PubMed ID: 32416209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift.
    Richardson ET; Selenica P; Pareja F; Cin PD; Hanlon E; Weigelt B; Reis-Filho JS; Hornick JL; Jo VY; Schnitt SJ
    Mod Pathol; 2023 Jun; 36(6):100144. PubMed ID: 36828363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NR4A3 fluorescence in situ hybridization analysis in cytologic and surgical specimens of acinic cell carcinoma.
    Shi Q; Zhang B; Bsirini C; Li L; Giampoli EJ; Magliocca KR; Reid M; Zhou Z
    Hum Pathol; 2022 Sep; 127():86-91. PubMed ID: 35700750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
    Haller F; Bieg M; Will R; Körner C; Weichenhan D; Bott A; Ishaque N; Lutsik P; Moskalev EA; Mueller SK; Bähr M; Woerner A; Kaiser B; Scherl C; Haderlein M; Kleinheinz K; Fietkau R; Iro H; Eils R; Hartmann A; Plass C; Wiemann S; Agaimy A
    Nat Commun; 2019 Jan; 10(1):368. PubMed ID: 30664630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of an immunocytochemical analysis for pan-Trk in the cytodiagnosis of secretory carcinoma of the salivary gland.
    Ito H; Ishida M; Ebisu Y; Okano K; Sandoh K; Noda Y; Miyasaka C; Fujisawa T; Yagi M; Iwai H; Tsuta K
    Diagn Cytopathol; 2021 Aug; 49(8):E329-E335. PubMed ID: 33885200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase VI: a novel marker for salivary serous acinar differentiation and its application to discriminate acinic cell carcinoma from mammary analogue secretory carcinoma of the salivary gland.
    Hsieh MS; Jeng YM; Jhuang YL; Chou YH; Lin CY
    Histopathology; 2016 Apr; 68(5):641-7. PubMed ID: 26212680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of clinicopathologic features and expression of NR4A3 in sinonasal acinic cell carcinoma.
    Wang H; Zhai C; Zhang C; Liu Q; Zhang H; Sun X; Lin L; Yu H; Wang D
    Mod Pathol; 2022 May; 35(5):594-600. PubMed ID: 34873305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of acinic cell carcinoma of the salivary gland on cytology specimens: Role of NOR-1 (NR4A3) immunohistochemistry.
    Meiklejohn K; Hrones M; Wang M; Prasad ML; Cai G; Adeniran A; Gilani SM
    Cytopathology; 2023 May; 34(3):219-224. PubMed ID: 36825365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.
    Abd Raboh NM; Hakim SA
    Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors.
    Rotellini M; Palomba A; Baroni G; Franchi A
    Appl Immunohistochem Mol Morphol; 2014; 22(5):390-4. PubMed ID: 23958548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and Neck Acinic Cell Carcinoma: A New Grading System Proposal and Diagnostic Utility of NR4A3 Immunohistochemistry.
    Xu B; Saliba M; Ho A; Viswanathan K; Alzumaili B; Dogan S; Ghossein R; Katabi N
    Am J Surg Pathol; 2022 Jul; 46(7):933-941. PubMed ID: 35034042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
    Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
    Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.